Finckh, Axel

 
 
Show items per page
Elements: 83
Page 2 on 2

2011

Scientific Articles

add to browser selection
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritisWaldburger, Jean-Marc; Palmer-Lourenco, Gaby; Seemayer, Christian Alexander; Lamacchia, Céline; ... Gabay, Cem
add to browser selection
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysisSalliot, Carine; Finckh, Axel; Katchamart, Wanruchada; Lu, Yan; ... Keystone, Edward
add to browser selection
Patient repositioning reproducibility of joint space with (JSW) measurements on hand radiographsNeumann, G; De Pablo, P; Finckh, Axel; Chibnik, L.B; ... Duryea, J
add to browser selection
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infectionJha, Rajneesh; Srivastava, Pragya; Salhan, Sudha; Finckh, Axel; ... Bas, Sylvette
add to browser selection
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single centerGabay, Cem; Medinger-Sadowski, Carole; Gascon, Danielle; Kolo Christophe, Frank; Finckh, Axel
add to browser selection
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort studyKyburz, Diego; Gabay, Cem; Michel, Beat A; Finckh, Axel;

Professional Articles

add to browser selection
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletionWalker, Ulrich A; Courvoisier, Delphine; Dudler, Jean; Aeberli, Daniel; ... Finckh, Axel

2010

Scientific Articles

add to browser selection
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesCurtis, Jeffrey R.; Jain, Archana; Askling, Johan; Bridges, S Louis Jr; ... Zink, Angela
add to browser selection
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trialGenevay, Stéphane; Viatte, Sébastien; Finckh, Axel; Zufferey, Pascal; ... Gabay, Cem
add to browser selection
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritisVuilleumier, Nicolas; Bas, Sylvette; Pagano, Sabrina; Montecucco, Fabrizio; ... Gabay, Cem
add to browser selection
Comparative effectiveness of rheumatoid arthritis therapiesFinckh, Axel;
add to browser selection
Cost-effectiveness of biologics in early rheumatoid arthritisFinckh, Axel; Bansback, Nick; Liang, Matthew H.;
add to browser selection
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patientsSingwe-Ngandeu, Madeleine; Finckh, Axel; Bas, Sylvette; Tiercy, Jean-Marie; Gabay, Cem
add to browser selection
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatologyDixon, William G.; Carmona, Loreto; Finckh, Axel; Hetland, Merete Lund; ... Askling, Johan
add to browser selection
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patientsFinckh, Axel; Dudler, Jean; Wermelinger, Felix; Ciurea, Adrian; ... Bas, Sylvette
add to browser selection
Osteoarthritis: Small studies overestimate the benefit of therapies for OAFinckh, Axel; Tramer, Martin;
add to browser selection
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritisDudler, Jean; Finckh, Axel; Kyburz, Diego; Langenegger, Thomas; ... Walker, Ulrich A.
add to browser selection
The effect of alcohol on radiographic progression in rheumatoid arthritisNissen, M. J.; Gabay, Cem; Scherer, A.; Finckh, Axel;
add to browser selection
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?Finckh, Axel; Ciurea, A.; Brulhart, L.; Moller, B.; ... Gabay, Cem

Thesis supervisions

add to browser selection
Comparaison du taux de rétention et des causes d'arrêt entre nfliximab, etanercept et adalimumab chez des patients avec polyarthrite rhumatoïdeMartin Du Pan Pruijm, Sophie;
| 1 | 2 | next >>